{"transactions":[{"id":1797517,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common stock","published_at":"2023-08-24T21:58:33.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.11,"value":166500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.045 to $1.15, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001493152-23-030111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/ownership.xml","form_type":"4"}},{"id":1801704,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common stock","published_at":"2023-08-18T20:21:49.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.1232,"value":28080.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001493152-23-029445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223029445/ownership.xml","form_type":"4"}},{"id":1860233,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:18.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020800/ownership.xml","form_type":"4"}},{"id":2092047,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Common stock","published_at":"2022-12-09T01:24:04.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":10000,"price":1.53,"value":15300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.53, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001493152-22-034969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315222034969/ownership.xml","form_type":"4"}},{"id":2494945,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Common stock","published_at":"2021-11-24T17:56:11.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":15000,"price":6.03,"value":90450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.05, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":215000,"source":{"system":"sec-edgar","filing":"0001493152-21-029774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029774/ownership.xml","form_type":"4"}},{"id":2541435,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:17.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":200000,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-025600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025600/ownership.xml","form_type":"4"}},{"id":2743870,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T01:44:21.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share in connection with the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are jointly held by the reporting person and Jennifer Rivard as trustees for the Paul Rivard and Jennifer Rivard Revocable Living Trust."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009302/ownership.xml","form_type":"4"}},{"id":2743869,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T01:44:21.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for a stock option to acquire 200,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009302/ownership.xml","form_type":"4"}}]}